Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.87), $0.04 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $131 million versus the consensus estimate of $128.07 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.